SAN DIEGO, July 27 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences:
| ||
Date: | Tuesday, August 3, 2010 | |
Time: | 1:35pm Eastern Time (10:35am Pacific Time) | |
Place: | Le Parker Meridien Hotel in New York City | |
Speaker: | Ted Schroeder, President & CEO | |
| ||
Date: | Thursday, August 12, 2010 | |
Time: | 1:00pm Eastern Time (10:00am Pacific Time) | |
Place: | Intercontinental Boston Hotel in Boston | |
Speaker: | Ted Schroeder, President & CEO | |
| ||
Date: | Friday, August 13, 2010 | |
Time: | 8:40am Eastern Time (5:40am Pacific Time) | |
Place: | Southampton Inn in Southampton, New York | |
Speaker: | William R. LaRue, SVP & CFO | |
Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals’ website at www.cadencepharm.com. To access the presentations, click on the Investor Relations tab the link entitled “Events and Presentations” on the left side of the screen. A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.
Contacts: | William R. LaRue SVP, CFO Cadence Pharmaceuticals, Inc. 858-436-1400 | |
SOURCE Cadence Pharmaceuticals, Inc.
